Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 244

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden

Open access
Nguyen, Long H, Örtqvist, Anne K, Cao, Yin, Simon, Tracey G, Roelstraete, Bjorn, Song, Mingyang, Joshi, Amit D, Staller, Kyle, Chan, Andrew T, Khalili, Hamed, Olén, Ola, Ludvigsson, Jonas F·2020·The Lancet Gastroenterology & Hepatology

Abstract

Background: Early life antibiotics have been linked to childhood inflammatory bowel disease (IBD), but data on adults is mixed—particularly for ulcerative colitis (UC)—and is based on smaller investigations that have not assessed risk among siblings with shared genetic/environmental risk factors. Our objective was to determine the association of antibiotic therapy and IBD in a large, population-based investigation. Methods: We conducted a population-based prospective case-control study of individuals aged ≥16 years in ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden), the Swedish Patient Register, and the Prescribed Drug Register to identify all consecutive cases of incident IBD (2007–2016) based on histology and ≥1 diagnosis code for IBD or its subtypes: UC and Crohn’s disease (CD). Cumulative antibiotic dispensations accrued until one year prior to the time of matching for both study cases and up to five general population controls matched on the basis of age, sex, county, and calendar year. We also included unaffected full siblings as a secondary control group. Conditional logistic regression was used to estimate multivariable-adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Findings: We identified 23,982 new IBD cases (15,951 UC, 7,898 CD, 133 IBD-unclassified), 28,732 siblings, and 117,827 controls. Prior use of antibiotics (never vs. ever) was associated with a nearly two-times increased risk of IBD after adjusting for several risk factors (aOR 1·94, 95% CI: 1·85–2·03). Compared to none, one (aOR 1·11, 95% CI: 1·07–1·15), two (aOR 1·38, 95% CI: 1·32–1·44) , and ≥three antibiotic dispensations (aOR 1·55, 95% CI: 1·49–1·61) were associated with increased odds of IBD compared to controls. Increased risk was noted for UC and CD with the highest estimates corresponding to broad-spectrum antibiotics. Notably, comparable, but attenuated results were observed when siblings served as the referent (aOR 1·35, 95% CI: 1·28–1·43). Interpretation: Higher cumulative exposure to systemic antibiotic therapy, particularly those with greater spectrum of microbial coverage, may be associated with an increase in risk for new-onset IBD and its subtypes. The association between antimicrobial treatment and IBD did not appear to differ when comparably predisposed siblings were used as the referent controls. Funding: National Institutes of Health; Crohn’s and Colitis Foundation

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30267-3

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 244

Metadata

Authors
Nguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., Olén, O., & Ludvigsson, J. F.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2020-11
Volume
5
Issue
11
Pages
986-995
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3049009424
Cited by
244
References
12
FWCI
17.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30267-3
The paper
Nguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., Olén, O., & Ludvigsson, J. F. (2020). Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30267-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.